[Prolactin and cancer of the prostate. IV. Prolactin inhibition in the treatment of prostatic cancer].
D000236:Adenoma / Q000150:complications; D001971:Bromocriptine / Q000627:therapeutic use; D002277:Carcinoma / Q000097:blood / Q000188:drug therapy*; D002369:Castration; D004967:Estrogens / Q000009:adverse effects; D006801:Humans; D007016:Hypophysectomy / Q000379:methods; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D009378:Neoplasms, Multiple Primary; D010146:Pain; D011388:Prolactin / Q000037:antagonists & inhibitors* / Q000097:blood / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy*
D004967:Estrogens; D001971:Bromocriptine; D007980:Levodopa; D011388:Prolactin
Prolactina y cáncer de próstata (y IV) inhibición de la prolactina en el tratamiento del cáncer prostático.